(Q53809366)

20 May 2018

title

A double-blind placebo-controlled trial of methylprednisolone pulse therapy in active rheumatoid disease. (English)

1 reference

20 May 2018

1 reference

placebo-controlled trial

1 reference

1 reference

I A Williams

1

1 reference

20 May 2018

E M Baylis

series ordinal

2

1 reference

20 May 2018

M E Shipley

series ordinal

3

1 reference

20 May 2018

language of work or name

English

0 references

publication date

1 July 1982

1 reference

20 May 2018

published in

The Lancet

1 reference

20 May 2018

volume

2

1 reference

20 May 2018

issue

8292

1 reference

20 May 2018

page(s)

237-240

1 reference

20 May 2018

STUDIES ON AN INTERMITTENT CORTICOSTEROID DOSAGE REGIMEN

cites work

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2882%2990323-3

7 January 2021

High dose intravenous methyl prednisolone (pulse therapy) in the treatment of rheumatoid disease

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2882%2990323-3

7 January 2021

Pulse methylprednisolone in rheumatoid arthritis: a double-blind cross-over trial

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2882%2990323-3

7 January 2021

Beneficial effects of methylprednisolone "pulse" therapy in diffuse proliferative lupus nephritis

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2882%2990323-3

7 January 2021

Serum immune complexes and disease activity in lupus nephritis

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2882%2990323-3

7 January 2021

Intravenous methylprednisolone pulses in diffuse proliferative lupus nephritis

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2882%2990323-3

7 January 2021

High-dose intravenous methylprednisolone pulse therapy in systemic lupus erythematosus

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2882%2990323-3

7 January 2021

Serious Pulmonary Hemorrhage, Glomerulonephritis, and Massive Steroid Therapy

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2882%2990323-3

7 January 2021

Pulse methylprednisolone therapy in idiopathic, rapidly progressive glomerulonephritis

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2882%2990323-3

7 January 2021

Methylprednisolone pulse therapy in the treatment of polyarteritis nodosa

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2882%2990323-3

7 January 2021

Intravenous methylprednisolone pulse therapy in severe ankylosing spondylitis

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2882%2990323-3

7 January 2021

Effects of a single large intravenous dose of methylprednisolone sodium succinate

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2882%2990323-3

7 January 2021

High dose intravenous methylprednisolone "pulse" therapy in patients with rheumatoid disease. Plasma methylprednisolone levels and adrenal function

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2882%2990323-3

7 January 2021

The effect of long term corticosteroid administration of lipid and prostaglandin levels

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2882%2990323-3

7 January 2021

The etiology of steroid-induced avascular necrosis of bone. A laboratory and clinical study

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2882%2990323-3

7 January 2021

Avascular necrosis following renal transplantation. Experience with 449 allografts with and without high-dose steroid therapy

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2882%2990323-3

7 January 2021

High intravenous doses of methylprednisolone for acute cadaveric renal allograft rejection

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2882%2990323-3

7 January 2021

Sudden death after methylprednisolone pulse therapy

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2882%2990323-3

7 January 2021

Fatal Arrhythmia After Pulse Methylprednisolone Therapy

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2882%2990323-3

7 January 2021

The Effect of In Vivo Hydrocortisone on Subpopulations of Human Lymphocytes

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2882%2990323-3

7 January 2021

Human lymphocyte subpopulations. Effect of corticosteroids

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2882%2990323-3

7 January 2021

Glucocorticoids Administered In Vivo Inhibit Human Suppressor T Lymphocyte Function and Diminish B Lymphocyte Responsiveness in In Vitro Immunoglobulin Synthesis

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2882%2990323-3

7 January 2021

Effects of corticosteroids on immunity in man. I. Decreased serum IgG concentration caused by 3 or 5 days of high doses of methylprednisolone

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2882%2990323-3

7 January 2021

10.1016/S0140-6736(82)90323-3

Identifiers

DOI

1 reference

20 May 2018

1 reference

20 May 2018